HUGroup Holdings (4544) AI Stock Analysis

• Market Cap: ¥191.75B
• Dividend Yield: 3.72%
• Average Volume (3M): 243.85K
• Price to Earnings (P/E): 33.5
• Beta (1Y): 0.40
• Revenue Growth: 2.93%
• EPS Growth: N/A
• Country: JP
• Employees: 5,295
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 95.82
• Shares Outstanding: 57,491,320
• 10 Day Avg. Volume: 223,460
• 30 Day Avg. Volume: 243,853
• PEG Ratio: -0.41
• Price to Book (P/B): 1.14
• Price to Sales (P/S): 0.64
• P/FCF Ratio: 8.72
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥4,370.00
• Price Target Upside: 17.19% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 97.89
• Revenue Forecast (FY): ¥250.26B

• Rating: 55 Neutral
• Price Target: ¥3,268.00 ▼(-12.36% Downside)
• Action: Reiterated Date: 02/11/26
• Date: Action: Reiterated 02/11/26

The score reflects improving fundamentals (return to profitability and moderate leverage) but still-thin margins and volatile free cash flow. Technicals are the main drag, with price below major moving averages and negative momentum indicators. Valuation is balanced by a solid dividend yield but offset by a high P/E.

Positive Factors

Business model & scale

HUGroup's core model—outsourced clinical lab testing—relies on long-term institutional relationships, centralized lab scale and a broad test menu. These structural attributes support durable volume-based economics, customer stickiness and cross-sell opportunities that sustain revenues over months.

Revenue growth and recovery

A return to positive EBIT and net income alongside +11.2% TTM revenue growth indicates improving demand and operational recovery. This trend, if sustained, underpins durable top-line momentum and provides a platform for gradual margin restoration over the next several quarters.

Manageable leverage

Debt-to-equity near 0.52, improved from earlier periods, suggests the balance sheet has room to absorb shocks and to fund targeted investments. Manageable leverage enhances financial flexibility and reduces refinancing risk over the medium term, supporting stable operations.

Negative Factors

Thin profitability

Very slim EBIT and net margins limit the firm's ability to absorb cost shocks or invest while preserving returns. Persistent low margins constrain incremental earnings leverage from revenue growth, making sustained margin improvement essential for durable shareholder value.

Volatile cash generation

Wide swings in free cash flow—large YoY decline and a prior year cash outflow—signal inconsistent conversion of earnings to cash. This volatility raises the risk that operating cycles or capex timing could pressure liquidity and constrain predictable reinvestment or dividends.

Low returns on equity

ROE near 2.8% indicates the business is not yet generating strong shareholder returns following the loss year. Even with improving revenue, low ROE implies capital is underemployed and that sustained operational improvement is required before returns reach peer or historical norms.

HUGroup Holdings Business Overview & Revenue Model

Company Description

HUGroup Holdings (4544) is a diversified financial services company based in Japan, primarily engaged in the insurance and asset management sectors. The company offers a range of products and services, including life insurance, non-life insurance, and investment management solutions, catering to both individual and corporate clients. With a focus on innovation and customer-centric solutions, HUGroup Holdings aims to enhance financial security and wealth management for its clients.

How the Company Makes Money

HUGroup Holdings generates revenue primarily through its insurance premiums from life and non-life insurance policies. The company collects premiums from policyholders in exchange for coverage against various risks, which constitutes a significant portion of its revenue stream. Additionally, HUGroup Holdings earns money through investment income generated from the premiums it collects, as these funds are invested in various financial instruments. The company also benefits from asset management fees charged to clients who utilize its investment management services. Strategic partnerships with financial institutions and distribution networks further bolster its earnings, allowing for a wider reach and customer base, thereby contributing to its overall revenue growth.

HUGroup Holdings Financial Statement Overview

Summary

Financials show an improving but not fully stabilized recovery: TTM returned to positive EBIT and net income with solid revenue growth (+11.2%), but profitability remains thin (net margin ~2.2%, EBIT margin ~3.8%) and below prior FY2021–FY2023 levels. Leverage is manageable (debt-to-equity ~0.52) yet returns are still low (ROE ~2.8%). Cash flow is positive (FCF ~¥18.5B) but volatile, with sharply lower TTM FCF (-64%) after a prior year of negative FCF.

Income Statement

TTM (Trailing-Twelve-Months) shows a clear earnings rebound versus FY2024 (returning to positive EBIT and net income) alongside solid top-line growth (+11.2%). However, profitability remains thin in TTM (net margin ~2.2%, EBIT margin ~3.8%) and is well below FY2021–FY2023 levels, indicating the recovery is still early and margins have not fully normalized.

Balance Sheet

Leverage looks manageable with debt-to-equity around ~0.52 in TTM, improved from FY2025 annual (~0.66) and below FY2021 levels (~0.70). That said, returns on equity are currently low (TTM ~2.8%) after the FY2024 loss year, suggesting the balance sheet is stable but not yet being utilized to generate strong shareholder returns.

Cash Flow

Cash generation is positive in TTM with free cash flow (~¥18.5B) and free cash flow tracking net income reasonably well (~0.88x). The main concern is volatility: TTM free cash flow is down sharply (growth -64%) and the prior year (FY2024) saw negative free cash flow, signaling inconsistent conversion and potential sensitivity to working capital and investment timing.

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	247.71B	243.03B	236.95B	260.91B	272.94B	223.02B
Gross Profit	70.51B	66.72B	63.23B	89.92B	111.80B	76.21B
EBITDA	31.44B	24.55B	13.65B	43.08B	56.34B	33.63B
Net Income	5.54B	2.76B	-7.55B	15.68B	29.60B	17.47B
Balance Sheet
Total Assets	272.92B	279.58B	290.85B	297.92B	286.59B	252.75B
Cash, Cash Equivalents and Short-Term Investments	47.84B	40.88B	39.95B	44.41B	46.71B	42.96B
Total Debt	70.29B	91.12B	81.94B	77.16B	73.00B	80.45B
Total Liabilities	137.81B	142.28B	148.34B	147.88B	146.41B	137.45B
Stockholders Equity	135.02B	137.29B	142.50B	150.04B	140.18B	115.31B
Cash Flow
Free Cash Flow	18.47B	17.88B	-1.01B	10.85B	20.10B	14.40B
Operating Cash Flow	20.87B	21.96B	16.55B	32.53B	55.23B	35.59B
Investing Cash Flow	2.59B	-15.96B	-16.05B	-29.58B	-30.86B	-28.27B
Financing Cash Flow	-16.68B	-5.30B	-5.78B	-5.76B	-21.73B	-1.57B

HUGroup Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 3729.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4544, the sentiment is Neutral. The current price of 3729 is above the 20-day moving average (MA) of 3217.80, above the 50-day MA of 3311.96, and above the 200-day MA of 3362.08, indicating a neutral trend. The MACD of -21.14 indicates Negative momentum. The RSI at 54.38 is Neutral, neither overbought nor oversold. The STOCH value of 62.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4544.

HUGroup Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3360	75 Outperform	¥238.68B	18.31	10.19%	2.19%	8.90%	-3.71%
3148	75 Outperform	¥214.94B	13.27	―	2.35%	7.55%	16.01%
9267	73 Outperform	¥138.14B	17.49	―	0.25%	9.97%	16.27%
6197	68 Neutral	¥90.19B	20.67	―	2.47%	1.86%	1370.48%
4544	55 Neutral	¥191.75B	33.47	2.65%	3.72%	2.93%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
4480	51 Neutral	¥64.95B	64.70	8.79%	―	31.95%	-40.95%

HUGroup Holdings Corporate Events

H.U. Group Cuts Profit Outlook but Holds Dividend Steady

H.U. Group Holdings has revised its full-year consolidated earnings forecast for the fiscal year ending March 31, 2026, trimming expected net sales to ¥250 billion and lowering projections for operating and ordinary profit. The changes reflect the partial divestment of Care’x Inc., which shifted from a consolidated subsidiary to an equity-method affiliate, pressuring reported sales.

Operating profit is now forecast at ¥6 billion, down 25% from the earlier outlook, as margins in the IVD business lag due to an unfavorable sales mix in existing CDMO products amid changing global market conditions. Fixed-cost reduction efforts in the LTS business have also underperformed, although profit attributable to owners of parent and the planned year-end dividend of ¥63 per share remain unchanged, signaling a commitment to shareholder returns despite weaker earnings momentum.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3229.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Lifts Nine-Month Profit, Confirms Dividend and Upgrades Full-Year Outlook

H.U. Group Holdings reported consolidated net sales of ¥186.7 billion for the nine months ended December 31, 2025, up 2.6% year on year, with operating profit surging 57.2% to ¥4.2 billion and profit attributable to owners of parent doubling to ¥5.6 billion, lifting basic earnings per share to ¥99.43. The company maintained a solid financial position with an equity ratio of 49.4%, confirmed its annual dividend forecast of ¥125 per share for the year ending March 31, 2026, and revised its full-year earnings outlook, now projecting modest sales growth but a sharp rebound in profit, underscoring improved profitability despite pressure on ordinary profit.

Total assets stood at ¥272.9 billion and net assets at ¥135.1 billion as of December 31, 2025, with net assets per share edging up to ¥2,431.72, reflecting stable balance sheet management. The company is also increasing treasury shares under its stock-based compensation plan, while planning an earnings briefing for institutional investors and analysts, signaling continued engagement with capital markets and a focus on enhancing shareholder value through both earnings recovery and consistent dividends.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3229.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Names Goki Ishikawa as New President and Group CEO to Drive ‘H.U. 2030’ Plan

H.U. Group Holdings has appointed Managing Executive Officer Goki Ishikawa as Representative Executive Officer, President and Group CEO, effective April 1, 2026, succeeding current Chairman, President and Group CEO Shigekazu Takeuchi, who will remain as Director and Executive Officer. The leadership transition is the result of a previously announced CEO succession plan aligned with the company’s “H.U. 2030” Medium-Term Management Plan, with the board citing Ishikawa’s strong track record in driving growth in the IVD business and leadership roles across key group companies as reasons he is best positioned to execute the next phase of the group’s long-term strategy.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3229.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports Strong Financial Performance for H1 2025

H.U. Group Holdings reported a significant improvement in its financial performance for the six months ended September 30, 2025, with a notable increase in operating profit by 143.2% year-on-year. The company’s net sales rose by 3.7%, indicating a steady growth trajectory. This positive financial outcome reflects the company’s strengthened market position and operational efficiency, which could have favorable implications for stakeholders and investors.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen4184.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.